Stockscreener 앱 받기
0.69%
시장 영업 전:
Mckesson Corporation 주식(MCK)의 최신 뉴스
McKesson (MCK): Morgan Stanley Raises Price Target to $810 | MCK Stock News - GuruFocus
McKesson (MCK) Sees Price Target Boost from Morgan Stanley | MCK Stock News - GuruFocus
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Yahoo Finance
Mckesson CEO Tyler S. Brian sells $13.7m in stock By Investing.com - Investing.com India
Mckesson CEO Tyler S. Brian sells $13.7m in stock - Investing.com
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson - openPR.com
Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies - Drug Topics
McKesson (MCK) Partners with Synergy CHC for Canadian Distributi - GuruFocus
Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America - The Manila Times
FOCUSfactor Secures Massive Retail Expansion: McKesson Canada Deal Opens Thousands of New Locations - Stock Titan
Government Contract Update: $1B payment to MCKESSON CORPORATION - Quiver Quantitative
McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead - Pharmacy Times
Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare - Drug Topics
McKesson Corporation (MCK): If It Was Down, I’d Say “Fill Her Up,” Says Jim Cramer - MSN
McKesson's Commitment to Independent Community Pharmacies Takes Center Stage | McKesson ideaShare - Drug Topics
McKesson ideaShare 2025: Pharmacy Technicians Drive Efficiency and Care - Pharmacy Times
Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare - Drug Topics
Evercore ISI Issues Positive Forecast for McKesson (NYSE:MCK) Stock Price - MarketBeat
How McKesson Ruling Will Inform Interpretations Of The TCPA - Law360
McKesson ideaShare 2025: Pharmacy Owner Keri Bates on Career Growth, Technician Pathways, and Building a Sustainable Pharmacy Team - Pharmacy Times
Financial Planning Remains Core Focus to Create Thriving Pharmacy Business | McKesson ideaShare - Drug Topics
Is McKesson Corporation (NYSE:MCK) Trading At A 34% Discount? - Yahoo Finance
Evercore ISI Adjusts Price Target on McKesson to $800 From $760, Maintains Outperform Rating - MarketScreener
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson stock hits all-time high, reaching $737.0 USD - Investing.com
Why Investors Shouldn't Be Surprised By McKesson Corporation's (NYSE:MCK) P/E - simplywall.st
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Yahoo Finance
Here's Why McKesson (MCK) is a Strong Growth Stock - Yahoo Finance
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Nimesh Jhaveri - McKesson
McLaughlin v. McKesson: Rebalancing the Scales Between Agency and Judicial Interpretation of the TCPA - Womble Bond Dickinson
Biologics by McKesson: Personalized Patient Care - McKesson
McKesson Newsroom: Latest Updates & Announcements - McKesson
Pharmaceutical Distribution & Solutions - McKesson
McKesson Supports Health System Pharmacy to Achieve More - McKesson
McKesson Business Solutions & GPO Strategies - McKesson
Maria N. Martinez - McKesson
Brian S. Tyler - McKesson
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington - CNBC
Atlas Specialty: Navigating Specialty Pharmacies - McKesson
W. Roy Dunbar - McKesson
McKesson's Impact: Safety, Preparedness & Opioids - McKesson
Mark Edwards - McKesson
Deborah Dunsire, M.D. - McKesson
Kathleen Wilson-Thompson - McKesson
Dave Ehlert - McKesson
Heather Easterling - McKesson
Joe DePinto, MBA - McKesson
Ginger Thorpe - McKesson
Oncology & Specialty Drug Distribution - McKesson
Francisco FragaExecutive Vice President, Chief Information Officer and Chief Technology Officer - McKesson
5 Ways McKesson is Globally Supporting COVID-19 Vaccination Efforts - McKesson
Craig Dolan - McKesson
McKesson is uniquely positioned to advance cancer care - McKesson
How two McKesson teams took on one of the most important endeavors to date - McKesson
Using Data to Bring Hope to Patients - McKesson
3PL: Efficient Therapy Distribution - McKesson
Empowering Pharmacy Ownership & Design - McKesson
Cancer Care & Clinical Trials - McKesson
Christopher Shain - McKesson
Ontada: Revolutionizing Oncology Care & Insights - McKesson
Britt VitaloneExecutive Vice President & Chief Financial Officer - McKesson
Empowering Independent Pharmacies with Health Mart - McKesson
Tom RodgersExecutive Vice President & Chief Strategy and Business Development Officer - McKesson
Kirk Kaminsky- President, U.S. Pharmaceutical - McKesson
Plasma & Biologics: Specialty Distribution - McKesson
The Bright Future of Community Oncology - McKesson
Pharmacy Management Software & Services Customer Resources - McKesson
Bridging the Healthcare Gap in Underserved Communities - McKesson
Download McKesson’s 2024 Corporate Impact Report - McKesson
Transform Your Health Experience with Foster & Thrive - McKesson
Biosimilar Drugs & Products - McKesson
Beyond the Battlefield with MMRG - McKesson
Affordable Access to Medicines - McKesson
Leading Oncology & Specialty Solutions - McKesson
Our Business Solutions - McKesson
1.08%
1.87%
자본화:
|
볼륨(24시간):